Innova Captab Share Price in Focus After Revised Results and Brownfield Expansion at Baddi Facility

Innova Captab announced revised audited financial results for the quarter and financial year ended March 31, 2026. The update provides details about the company’s financial performance and further, the Board of Directors of the company have approved a brownfield expansion of the existing Baddi Manufacturing facility. 

Innova Captab Brownfield Expansion at Baddi Facility 

Innova Captab along with the revised consolidated results, approved a brownfield expansion of its existing manufacturing facility located at Baddi, Himachal Pradesh. The expansion will be carried out within the existing premises at 81 B, EPIP Phase I, Jharmajri, Baddi. The proposed expansion includes expansion includes the addition of 2 oral solid (tablets/capsules) dosage production lines.  

Investment required for expansion is approximately ₹45 crore. Mode of financing for the proposed expansion will be financed through a combination of bank credit facilities and company’s internal accruals.  

Revised Consolidated Results of Innova Captab for Qaurtern Ended March and FY26 

Innova Captab's revised consolidated revenue from operations for the quarter that ended on March 31, 2026, was ₹447.80 crore, which is a jump of 42.28% from the same time last year when it was ₹314.74 crore. The company also saw a significant increase in net profit, which rose by 41.20% to ₹40.35 crore during the same quarter.  

For FY26, Innova Captab’s consolidated revenue from operations increased 31.05% YoY to ₹1,630.02 crore, while net profit rose 12.52% YoY to ₹143.18 crore.  

The revised financial statements were issued after the company corrected certain inadvertent errors identified in the earlier consolidated financial results. The corrections included adjustments related to prior year financial information and deferred tax treatment. 

Innova Captab Share Price Performance  

On August 21, 2026, Innova Captab share price closed at ₹1,088.50 up by 0.40% on NSE.  

Read More: Strides Pharma Share Price Surges 3%; Receives USFDA EIR for Bengaluru Facility! 

Conclusion 

Innova Captab consolidated results present an updated picture of the company’s financial performance, with the March 2026 quarter showing higher revenue and profit compared with the corresponding period last year. The brownfield expansion announcement adds another operational update as the company continues to enhance its manufacturing footprint. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.